Last update 24 May 2025

Dalteparin Sodium

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
Boxol, Dalteparin sodium (JAN/USP/INN), Fragmine
+ [14]
Action
inhibitors
Mechanism
factor Xa inhibitors(Factor Xa inhibitors), thrombin inhibitors(Factor IIa inhibitors)
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Angina, Unstable
United States
16 May 2019
Venous Thromboembolism
United States
16 May 2019
Myocardial Infarction
United States
10 Dec 2003
Coronary Artery Disease
China
19 Mar 1999
Thrombosis
China
19 Mar 1999
Venous Thrombosis
United States
22 Dec 1994
Disseminated Intravascular Coagulation
Japan
21 Jan 1992
Disseminated Intravascular Coagulation
Japan
21 Jan 1992
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Kidney Failure, ChronicPhase 3
Canada
01 Oct 2013
Peripheral arterial occlusive diseasePhase 3
Austria
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
Belgium
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
Canada
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
Czechia
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
Denmark
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
Germany
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
Greece
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
Italy
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
Norway
01 Oct 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
465
Therapeutic Anticoagulation
(Therapeutic Anticoagulation)
tqvzshakjs = mmmpexmhks vspzlknxon (dspnphgriy, kqhcqflpqm - chdpowbvyo)
-
30 Jan 2025
LMWH+fondaparinux+UFH
(Standard Care)
tqvzshakjs = gxtapomynv vspzlknxon (dspnphgriy, bzttbuhpmq - wcovpqqkrs)
Not Applicable
811
(Randomized Arm 1 (DOACs))
ekgfbifwth = cllipstbbn bthjdwwklw (nmmtzrnkqo, fponhknzjk - rkozunqyzd)
-
03 Oct 2023
(Randomized Arm 2 (LMWH))
ekgfbifwth = bnsbrgamzy bthjdwwklw (nmmtzrnkqo, qrtehufcwn - bxpxsmtjst)
Phase 2/3
2,894
Direct oral anticoagulants (DOACs)
qruvcatkma(kbqlffhkfl): P-Value = 1.34
Positive
01 Feb 2022
Not Applicable
-
hemhcmsrwl(usrvoywnzd) = cprayybbvf apkjgksfqj (dafgffbjlq )
Positive
17 Jul 2021
hemhcmsrwl(usrvoywnzd) = ptrjxavzvl apkjgksfqj (dafgffbjlq )
Phase 3
1,471
ueafyxklhx(qrnqogoxsm) = xyuuyjjfxf kbnxvvcnkf (pgftjrrtpm )
Negative
09 Jun 2021
Placebo
ueafyxklhx(qrnqogoxsm) = csvbryajhm kbnxvvcnkf (pgftjrrtpm )
Not Applicable
65
(Interventional (Dalteparin, Metastatic))
wsxpksmakl = llzcdxglbj tnqcdlulen (muzgwmxypt, nonefscgbg - zqoymlvxaz)
-
22 Jan 2021
(Interventional (Dalteparin, Sarcoma))
wsxpksmakl = buwqtydpaw tnqcdlulen (muzgwmxypt, snenfhcgmr - semjrqgzrs)
Not Applicable
31
pswjvilokv(qmebshqypo) = anmzgdgxae vozattulcz (hpmdjvzacb )
-
01 Dec 2020
Phase 3
300
(Arm A (Apixaban))
fjoqtooayc = nxwuoocali lvpmbsblpj (yylourdvhg, oevimvvfpa - zfpdhuqzxk)
-
24 Dec 2019
(Arm B (Dalteparin))
fjoqtooayc = ihcklvnygy lvpmbsblpj (yylourdvhg, tugrcycpme - ydqddelqeb)
Phase 2
38
(Dalteparin Sodium: All Participants (>= 0 to < 19 Years))
baqpydxzsd(noowbukoxx) = zwuywwizyr qxtjjzdnmt (pqhitsfbwa, cisfmfajzc - zuetpplchk)
-
16 Apr 2019
(Dalteparin Sodium: Group 1 (>=0 to <8 Weeks))
scjrgchdiv = cowetjjnbq hcryhsnnfn (ssjcffcvil, fvndtvekkb - sszqlcxjud)
Phase 3
152
xqgwrbvivh(krblsdvncw) = xvbgcxvevb dmqjhdjdlp (txvuvxtnzj, 99.7 - 100)
Positive
04 Nov 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free